Public record. Every entry links to its official government source. Free to read · non-partisan Free to read, always
Civic Candor The record of Congress

What Congress did, and what happened next.

Bill · 119th Congress

H.R. 1051

To amend the Federal Food, Drug, and Cosmetic Act to allow for the approval of an abbreviated new drug application submitted by a subsequent applicant in the case of a failure by a first applicant to commence commercial marketing within a certain period, and for other purposes.

Introduced 2025-02-06 by Nikki Budzinski.

Latest action on file, 2025-02-06: Referred to the House Committee on Energy and Commerce.

Policy area: Health.

Source: Congress.gov

Loading this bill…